SRPT Sarepta Therapeutics, Inc.
$18.67
Sarepta Therapeutics, Inc. (SRPT) is expected to report earnings on November 3, 2026, after the market close. The consensus earnings estimate is $0.30 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +12.1% since its last earnings release on August 5, 2026.
Sarepta Therapeutics Beat Consensus Estimates
Wednesday, August 5, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs $0.30
Rev est $351.4M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$20.05
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases.
Sector
Healthcare
Industry
Biotechnology
Held By 10 ETFs, by dollar flow
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- BMED iShares Health Innovation Active ETF
- BMED iShares Health Innovation Active ETF
- BBH VanEck Biotech ETF
- BBH VanEck Biotech ETF
- IBRN iShares Neuroscience and Healthcare ETF
- IBRN iShares Neuroscience and Healthcare ETF
Charts powered in part by Lightweight Charts™ by TradingView.